Prevalence of Osteosarcopenic Obesity in Older Adults

Prevalence of Osteosarcopenic Obesity in Older Community-dwelling Adults in Turkey

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04288401

Enrollment

460

Registered

2020-02-28

Start date

2020-02-25

Completion date

2020-04-01

Last updated

2020-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Osteopenia, Osteoporosis, Sarcopenia

Brief summary

Osteosarcopenic Obesity (OSO) is a syndrome characterized by the loss of bone and muscle in addition to increase in the fat tissue as a result of aging process. It is the latest point of impairment in the bone,muscle and adipose tissue in older adults. OSO, as the name suggests, is the combination of three syndrome frequently encountered in the elderly: osteopenia/osteoporosis, sarcopenia and obesity. The aims of study are to determine the prevalence of OSO syndrome in community-dwelling adults of Turkey and determine the possible factors regarding risk of falling in this population

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

65 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Age of 65 or over * Being had been examined for all the primary outcome measures (i.e. the results of primary outcomes must be in the patient's file)

Exclusion criteria

* Severe cognitive dysfunction * not being able to walk independently for 4 m

Design outcomes

Primary

Measure	Time frame	Description
Obesity	2 minutes	The fat percentage and the Body Mass Index measured by bioimpedance analysis using Tanita TBF300 is recorded. For BMI, 30 kg/m2 and over is classified as obesity whereas fat percentage of %35 and %28 (woman and man, respectively) and over was classified as obese.
Muscle Strength	5 minutes	Measured by hand held dynamometer. The cut-off scores for man and woman are 27 kg and 16 kg, respectively
Muscle Mass	2 minutes	Measured by bioimpedance analysis using Tanita TBF300. The cut-off scores for man and woman are 9,2 kg/m2 and 7,4 kg/m2, respectively
Muscle Performance	3 minutes	Tested by 4 meter walk test. If the gait speed is lower than 0,8 m/s, the test is positive.
T score	1 hour	T scores of spine and femur neck examined with Dual X-Ray Absorptiometry. A T score\<-2,5 will be classified as osteoporosis while a T score between -1 and -2,5 will be counted as osteopenia

Secondary

Measure	Time frame	Description
History of falls	1 minutes	A patient's self stated history of falls will be considered as having a history of fall or not.
Comorbidity	3 minutes	Using Charlson Comorbidity Index

Countries

Turkey (Türkiye)

Outcome results